The role of anaemia and foetal haemoglobin in Sickle Cell Disease: Clinical epidemiology to establish the evidence base for interventional trials of blood transfusion and Hydroxyurea. (360G-Wellcome-093727_Z_10_Z)

Severe anaemia is a major cause of morbidity and mortality in SCA. HbF is a major factor influencing anaemia, BT requirement and outcome. There is no information on HbF in East Africa. I propose to examine the association of HbF and severe anaemia in Tanzanian SCA patients. BT is the mainstay of management but concerns about safety, supply and cost have prompted a search for alternative interventions. Hydroxyurea is used in SCA in North America and Europe; effectively reducing morbidity (pain , hospitalisation, BT) and mortality. Its main efficacy is increasing HbF levels, but this has not been consistently reported. Other mechanisms include reduced inflammation and vasculopathy. There is inadequate information on its efficacy, mechanism of action and safety in Africa as it would be an alternative for BT. I will describe the response to hydroxyurea in SCA; determine the toxicity, optimal dosing and monitoring regime. In identifying patients for hydroxyurea treatment, I will dete rmine and treat known causes of severe anaemia such as infections (malaria, bacteraemia, parvovirus), splenic sequestration and nutritional deficiency (folic acid, vitamin A, B12, iron). This fellowship will provide the evidence on HbF and hydroxyurea required to conduct clinical trials and improve management of severe anaemia.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region International
Award Date 2010-11-23T00:00:00+00:00
Sponsor(s) Prof Kevin Marsh, Prof Ephata Kaaya, Prof Charles Newton, Prof Swee Thein
Internal ID 093727/Z/10/Z
Planned Dates: End Date 2017-03-31T00:00:00+00:00
Planned Dates: Start Date 2012-04-01T00:00:00+00:00
Amount Awarded 846079
Financial Year 2010/11
Lead Applicant Prof Julie Makani
Grant Programme: Title International Intermediate Fellowship
Applicant Surname Makani
Approval Committee International Interview Committee
Recipient Org: Country Tanzania
Recipient Org: City Upanga, Dar es Salaam
Has the grant transferred? No
Research conducted at multiple locations? Yes
Total amount including partnership funding 846079

Help shape the next 10 years of GrantNav!

GrantNav is celebrating its 10th anniversary. Take our quick 3-minute survey to tell us how we can make the data work better for you.

Take the Survey